These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 8547220

  • 1. Conditional binding to and cell cycle-regulated inhibition of cyclin-dependent kinase complexes by p27Kip1.
    Eblen ST, Fautsch MP, Anders RA, Leof EB.
    Cell Growth Differ; 1995 Aug; 6(8):915-25. PubMed ID: 8547220
    [Abstract] [Full Text] [Related]

  • 2. Herpes simplex virus type 1 infection imposes a G(1)/S block in asynchronously growing cells and prevents G(1) entry in quiescent cells.
    Ehmann GL, McLean TI, Bachenheimer SL.
    Virology; 2000 Feb 15; 267(2):335-49. PubMed ID: 10662629
    [Abstract] [Full Text] [Related]

  • 3. TGF-beta mediated G1 arrest in a human melanoma cell line lacking p15INK4B: evidence for cooperation between p21Cip1/WAF1 and p27Kip1.
    Flørenes VA, Bhattacharya N, Bani MR, Ben-David Y, Kerbel RS, Slingerland JM.
    Oncogene; 1996 Dec 05; 13(11):2447-57. PubMed ID: 8957087
    [Abstract] [Full Text] [Related]

  • 4. [G1 block of the cell cycle during differentiation of F9 cells correlates with accumulation of inhibitors of the activity of cyclin-kinase complexes of proteins p21/Waf1 and p27/Kip].
    Malashicheva AB, Kisliakova TV, Pospelov VA.
    Tsitologiia; 2002 Dec 05; 44(7):649-55. PubMed ID: 12455373
    [Abstract] [Full Text] [Related]

  • 5. The role of p27Kip1 in gamma interferon-mediated growth arrest of mammary epithelial cells and related defects in mammary carcinoma cells.
    Harvat BL, Seth P, Jetten AM.
    Oncogene; 1997 May 01; 14(17):2111-22. PubMed ID: 9160891
    [Abstract] [Full Text] [Related]

  • 6. Withdrawal of differentiation inhibitory activity/leukemia inhibitory factor up-regulates D-type cyclins and cyclin-dependent kinase inhibitors in mouse embryonic stem cells.
    Savatier P, Lapillonne H, van Grunsven LA, Rudkin BB, Samarut J.
    Oncogene; 1996 Jan 18; 12(2):309-22. PubMed ID: 8570208
    [Abstract] [Full Text] [Related]

  • 7. Differential expression of the cyclin-dependent kinase inhibitor P27 in primary hepatocytes in early-mid G1 and G1/S transitions.
    McIntyre M, Desdouets C, Sénamaud-Beaufort C, Laurent-Winter C, Lamas E, Bréchot C.
    Oncogene; 1999 Aug 12; 18(32):4577-85. PubMed ID: 10467402
    [Abstract] [Full Text] [Related]

  • 8. c-myc-enhanced S phase entry in keratinocytes is associated with positive and negative effects on cyclin-dependent kinases.
    Alexandrow MG, Moses HL.
    J Cell Biochem; 1998 Sep 15; 70(4):528-42. PubMed ID: 9712150
    [Abstract] [Full Text] [Related]

  • 9. A cyclin-dependent kinase inhibitor, butyrolactone I, inhibits phosphorylation of RB protein and cell cycle progression.
    Kitagawa M, Higashi H, Takahashi IS, Okabe T, Ogino H, Taya Y, Hishimura S, Okuyama A.
    Oncogene; 1994 Sep 15; 9(9):2549-57. PubMed ID: 8058318
    [Abstract] [Full Text] [Related]

  • 10. Impairment of rat postnatal lung alveolar development by glucocorticoids: involvement of the p21CIP1 and p27KIP1 cyclin-dependent kinase inhibitors.
    Corroyer S, Schittny JC, Djonov V, Burri PH, Clement A.
    Pediatr Res; 2002 Feb 15; 51(2):169-76. PubMed ID: 11809910
    [Abstract] [Full Text] [Related]

  • 11. Cooperation between Cdk4 and p27kip1 in tumor development: a preclinical model to evaluate cell cycle inhibitors with therapeutic activity.
    Sotillo R, Renner O, Dubus P, Ruiz-Cabello J, Martín-Caballero J, Barbacid M, Carnero A, Malumbres M.
    Cancer Res; 2005 May 01; 65(9):3846-52. PubMed ID: 15867383
    [Abstract] [Full Text] [Related]

  • 12. Molecular basis for the lack of T cell proliferation induced by an altered peptide ligand.
    Grakoui A, VanDyk LF, Dowdy SF, Allen PM.
    Int Immunol; 1998 Jul 01; 10(7):969-79. PubMed ID: 9701035
    [Abstract] [Full Text] [Related]

  • 13. Increased expression of the P27KIP1 protein in human esophageal cancer cell lines that over-express cyclin D1.
    Doki Y, Imoto M, Han EK, Sgambato A, Weinstein IB.
    Carcinogenesis; 1997 Jun 01; 18(6):1139-48. PubMed ID: 9214595
    [Abstract] [Full Text] [Related]

  • 14. From simple to complex patterns of oscillatory behavior in a model for the mammalian cell cycle containing multiple oscillatory circuits.
    Gérard C, Goldbeter A.
    Chaos; 2010 Dec 01; 20(4):045109. PubMed ID: 21198121
    [Abstract] [Full Text] [Related]

  • 15. Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution.
    Lee MH, Reynisdóttir I, Massagué J.
    Genes Dev; 1995 Mar 15; 9(6):639-49. PubMed ID: 7729683
    [Abstract] [Full Text] [Related]

  • 16. Cyclin-dependent kinase regulation during G1 phase and cell cycle regulation by TGF-beta.
    Ravitz MJ, Wenner CE.
    Adv Cancer Res; 1997 Mar 15; 71():165-207. PubMed ID: 9111866
    [Abstract] [Full Text] [Related]

  • 17. Abrogation of p27Kip1 by cDNA antisense suppresses quiescence (G0 state) in fibroblasts.
    Rivard N, L'Allemain G, Bartek J, Pouysségur J.
    J Biol Chem; 1996 Aug 02; 271(31):18337-41. PubMed ID: 8702474
    [Abstract] [Full Text] [Related]

  • 18. Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation.
    Montagnoli A, Fiore F, Eytan E, Carrano AC, Draetta GF, Hershko A, Pagano M.
    Genes Dev; 1999 May 01; 13(9):1181-9. PubMed ID: 10323868
    [Abstract] [Full Text] [Related]

  • 19. p27KIP1, an inhibitor of cyclin-dependent kinases.
    Koff A, Polyak K.
    Prog Cell Cycle Res; 1995 May 01; 1():141-7. PubMed ID: 9552359
    [Abstract] [Full Text] [Related]

  • 20. Ras activity late in G1 phase required for p27kip1 downregulation, passage through the restriction point, and entry into S phase in growth factor-stimulated NIH 3T3 fibroblasts.
    Takuwa N, Takuwa Y.
    Mol Cell Biol; 1997 Sep 01; 17(9):5348-58. PubMed ID: 9271412
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.